Sequoya’s has achieved its first step to become a significant GMP-certified hemp CBD supplier, with longer term plans to expand into the legal medical marijuana market across Europe. Sequoya’s recently completed cannabis extraction operations are located in Krakow, Poland, with plans to become a leading supplier of CBD extracts and isolate within the European Union (“EU”).
The Sequoya facility is built from the ground up with the strictest production, quality and safety standards. allowing quick and smooth certification of the entire facility and it marks the only completely end-to-end EU GMP certified hemp extraction facility in Europe. Sequoya’s facility, completed in January 2020 is the most modern facility in Europe, utilizing Canadian CO2 clean extraction machines and top end Swiss Laboratory Instruments for product purification, formulation and volume production. As an end-to-end EU GMP Certified facility, it includes a modern, fully equipped Analysis & Quality Control Area, staffed with Sr. R&D and Quality Specialists ensuring tight control over producing consistent and highest quality results. Sequoya is now partnering with some of the world’s biggest consumer brands as their CBD supplier. With little regulatory hurdles around CBD in Europe, Sequoya is receiving tremendous interest from consumer goods manufacturers. Namely, from cosmetics, food & amp; beverage and nutraceutical companies with interest continuing to grow across all segments.
MMJ expects Sequoya to provide excellent investment returns:
MMJ’s investment consists of a CAD2.5m convertible note issued by and a 24% ordinary shareholding in Sequoya.
MMJ has also secured the rights to make further investments in Sequoya through:
1 GMP stands for Good Manufacturing Practices, and refers to a system of manufacturing that guarantees reproducibility of product quality to set specifications
2 Cannabidiol (CBD) is a crystalline, nonintoxicating cannabinoid in cannabis and hemp